Showing results (161-170 of 219) with videos related to
Sort By:
Pageof 22
Annals of Surgical Oncology|March 5, 2009
Role of sentinel lymph node biopsy in the staging of synovial, epithelioid, and clear cell sarcomasUgwuji N Maduekwe, Francis J Hornicek, Dempsey S Springfield, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2024
A Translational Study of the ATR Inhibitor Berzosertib as Monotherapy in Four Molecularly Defined Cohorts of Advanced Solid TumorsGregory M Cote, Bose S Kochupurakkal, Khanh Do, et al.Advances in Radiation Oncology|July 26, 2017
Phase 1 trial of preoperative image guided intensity modulated proton radiation therapy with simultaneously integrated boost to the high risk margin for retroperitoneal sarcomasThomas F DeLaney, Yen-Lin Chen, Elizabeth H Baldini, et al.Journal of Surgical Oncology|October 30, 2016
Clinical outcomes for patients after surgery and radiation therapy for mesenchymal chondrosarcomasKaren De Amorim Bernstein, Norbert Liebsch, Yen-Lin Chen, et al.Annals of Surgical Oncology|September 12, 2012
Desmoid tumor: analysis of prognostic factors and outcomes in a surgical seriesJohn T Mullen, Thomas F Delaney, Wendy K Kobayashi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2023
SAR-096: Phase II Clinical Trial of Ribociclib in Combination with Everolimus in Advanced Dedifferentiated Liposarcoma (DDL) and Leiomyosarcoma (LMS)Sujana Movva, Sahar Matloob, Elizabeth A Handorf, et al.Cancer Medicine|June 12, 2023
Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcomaDavid S Shulman, Priscilla Merriam, Edwin Choy, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 27, 2020
Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced ChondrosarcomaWilliam D Tap, Victor M Villalobos, Gregory M Cote, et al.Skeletal Radiology|March 21, 2026
Soft tissue reporting and data system (soft tissue-RADS): framework for radiologists specializing in imaging of musculoskeletal tumors and tumor-like lesionsAvneesh Chhabra, Mark D Murphey, Mahad Rehman, et al.The Oncologist|August 21, 2013
β-Catenin mutation status and outcomes in sporadic desmoid tumorsJohn T Mullen, Thomas F DeLaney, Andrew E Rosenberg, et al.Pageof 22